The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change+33.5% to $132.00
Predicted High$132.00at 6 months
Predicted Low$95.00at 1 month
Max Drawdown (predicted)-3.9%
Forecast
The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded.
Predicted Jul 31, 2026 2:08 am
Bull
NICE trends higher to
$132.00
(+33.5% from $98.88)
by Jan 2027.
dip-then-recover
ThesisNICE trades at a deep discount to composite fair value ($207) with strong quality (80/100) and 5-of-5 earnings beats, but heavy negative sentiment and a fresh 5.9% drop suggest near-term drift lower before value gravity pulls it higher over the 6-month window. The path is dip-then-recover: sentiment dominates the first month, then mean reversion and earnings catalysts drive a gradual climb well short of the deterministic $164 endpoint.
Invalidated ifA break below $85 on rising volume, or a guidance cut/miss on the next earnings print, would invalidate the recovery thesis.
Checkpointtime after the call
Datewhen it gets graded
Predictedthe claim: closing price
Current priceactual close — fills in over time
Predicted returnpredicted vs $98.88 at call
Conv.brain's confidence, 1–10
Driverwhy the brain put the point here
Prediction made
Jul 31, 2026
—
$98.88at call
—
—
The anchor — every point below is measured from this price and date.
2 weeks
Aug 14, 2026
$84.37–$113.39typical range · internal point $96.50
—
±14.7%
7/10
Fresh sentiment shock and momentum extend near-term drift
What actually happened:
closed $105.25
on Aug 13, 2026 = +6.4% vs the call
(predicted -2.4%)
· direction MISS
(called flat, was up)
· off by 8.9 pp
· accuracy 4/10
· typical range ±14.7%:
inside the band
· S&P +4.1%
over the same window — lagged it
1 month
Aug 31, 2026
$77.86–$119.90typical range · internal point $95.00
—
±21.3%
6/10
Fallen-angel narrative caps rebound attempts near lows
2 months
Oct 1, 2026
$101.00
—
+2.1%
5/10
Oversold bounce as sellers exhaust below fair value
3 months
Oct 31, 2026
$108.00
—
+9.2%
5/10
Earnings beat streak reasserts, value buyers step in
Why ranges on the short rungs?
A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here —
three prompt formulations all lost to simply predicting zero — while the stock's own
volatility scale (σ×√t) described those windows well. So the short rungs claim what's
actually knowable: the typical travel, with earnings timing flagged where the variance
will come from. The internal point calls keep being generated and graded to map where
real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.
Deterministic control (v0.3 value line) targets
$163.64
(+65.5%)
— both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it.
Brain: claude-opus-4-7.